All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

Clinical Pharmacology: Advances and Applications

ISSN Print: 1179-1438

ISSN Online:

Website: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journal

Share:




Go

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia

Portell CA,Wenzell CM,Advani AS

Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

Davis EM,Knezevich JT,Teply RM

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation

van Rossem K,Lowe JA

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven®)

Bartosh NS,Tomlin T,Cable C,Halka K

Effect of statin therapy on vaspin levels in type 2 diabetic patients

Al-Azzam SI,Alzoubi KH,Abu Abeeleh J,Mhaidat NM

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. [Corrigendum]

Nanda K,Moss AC

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Upreti VV,Song Y,Wang J,Byon W

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Kreutz RP, Nystrom P, Kreutz Y, Miao J, Desta Z, Breall JA, Li L, Chiang C, Kovacs R, Flockhart DA, Jin Y

Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features

Seki M, Yabuno K, Miyawaki K, Miwa Y, Tomono K

Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid

Gandy JJ, Meeding JP, Snyman JR, Janse van Rensburg CE

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

Hashemi SN, Ghafarian Shirazi HR, Mohammadi A, Zadeh-Bagheri GH, Noorian KH, Malekzadeh M

Smoking cessation

Kaur K, Juneja S, Kaushal S

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations

Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L

Erratum

Barrese V, Miceli F, Soldovieri MV, Ambrosino P, Iannotti FA, Cilio MR, Taglialatela M

Erratum

Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L

Sedation in the intensive care setting

Hughes CG, McGrane S, Pandharipande PP

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX mesalamine

Nanda K, Moss AC

Pazopanib for the treatment of soft-tissue sarcoma

Heudel P, Cassier P, Derbel O, Dufresne A, Meeus P, Thiesse P, Ranchère-Vince D, Blay JY, Ray-Coquard I

Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid

Gandy JJ,Meeding JP,Snyman JR,Janse van Rensburg CE

Pazopanib for the treatment of soft-tissue sarcoma

Heudel P,Cassier P,Derbel O,Dufresne A

Sedation in the intensive care setting

Hughes CG,McGrane S,Pandharipande PP

Erratum

Samtani MN,Sheehan JJ,Fu D-J,Remmerie B

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine

Nanda K,Moss AC

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

Hashemi SN,Ghafarian Shirazi HR,Mohammadi A,Zadeh-Bagheri GH

Arginine deprivation therapy for malignant melanoma

Yoon JK,Frankel AE,Feun LG,Ekmekcioglu S

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing

Thomas RP,Recht L,Nagpal S

Erratum

Barrese V,Miceli F,Soldovieri MV,Ambrosino P

Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features

Seki M,Yabuno K,Miyawaki K,Miwa Y

Smoking cessation

Kaur K,Juneja S,Kaushal S

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Kreutz RP,Nystrom P,Kreutz Y,Miao J

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations

Samtani MN,Sheehan JJ,Fu D-J,Remmerie B

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

Ohanian M, Cable C, Halka K

Drug-resistant tuberculosis: emerging treatment options

Adhvaryu MR, Vakharia BC

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Ohanian M, Cable CC, Halka KK

A case of cephalothin-associated urolithiasis

Ivan WM Lim, Peter JO Stride, Robert L Horvath

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions

Mahamid M, Mader R, Safadi R

Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole

Patel C, Li L, Girgis S, Kornhauser D, Frevert E, Boulton D

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions

Mahamid M,Mader R,Safadi R

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole

Patel C,Li L,Girgis S,Kornhauser D

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Ohanian M,Cable CC,Halka KK

A case of cephalothin-associated urolithiasis

Ivan WM Lim,Peter JO Stride,Robert L Horvath

Drug-resistant tuberculosis: emerging treatment options

Adhvaryu MR,Vakharia BC

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

Ohanian M,Cable C,Halka K

Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis

P Brandon Bookstaver, Katherine R Gerrald, Robert R Moran

Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying

Richard Kones

The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?

Rakesh K Sharma, Hanumanth K Reddy, Rohit K Sharma, et al

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy

Joe D Strain, Debra K Farver, James R Clem

Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer treatment and/or higher doses?

Sayeeda Rahman, Aziz Al-Shafi Ismail, Shaiful Bhari Ismail, et al

Go




©2008-2017 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705